Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05550324

IPSC Repository of Pediatric Cardiovascular Disease

Obtain blood samples for generation and maintenance of induced pluripotent stem cells (iPSCs) and genomic/DNA sequencing for biomedical research that will improve the understanding and treatment of pediatric cardiovascular disease

Recruiting

Interested in participating?

Request Info

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Nationwide Children's Hospital

Columbus, Ohio, 43205, United States

Location status: Recruiting

Location contact

Jade Hayden

CONTACT

[email protected]

16143555648

About this study

Human induced pluripotent stem cells (iPSCs) are a type of pluripotent stem cell which can be generated from easily accessible patient cells, such as peripheral blood mononuclear cells and skin fibroblasts. As iPSCs are epigenetically reprogrammed from somatic cells, they retain all genetic information of the affected patients, thus providing an ideal model for studying the contribution of genetic variation to pediatric cardiovascular disease. In addition, human iPSCs can be differentiated into cardiomyocytes, endothelial cells, smooth muscle cells and cardiac fibroblasts, which are major affected cell types in the heart responsible for cardiovascular disease. Therefore, patient-specific iPSCs possess great promise in modeling pediatric cardiovascular disease, discovering novel drugs and prospective cell regeneration therapy.

The DNA from these patients will be analyzed for point mutations, rare sequence variations, single nucleotide polymorphisms in known cardiac development genes or for chromosomal copy number changes by using state of the art genetic approaches.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The subjects must have the diagnosis of cardiovascular disease
  • The subject must have a syndrome associated with cardiovascular disease
  • The subject must be related to an individual in cohort 1 or 2
  • The subject is considered a control and does not fall into any of the other cohorts

Exclusion criteria

N/A

Treatment and study plan

Blood draw

Procedure

One time intravenous blood draw

Primary outcomes

  1. improve the understanding and treatment of pediatric cardiovascular disease

    Time frame: up to 10 Years

    This is a repository of blood samples that will be used into the future for medical research to improve the understanding and treatment of pediatric cardiovascular disease

Study contacts

Contact information is provided by the study sponsor or research team.

Jade F Hayden, BSN

CONTACT

[email protected]

16143555648

Sponsors and collaborators

Lead sponsor

Mingtao Zhao

Other

Registry information

Important dates

Study start
2021
Primary completion
2030
Study completion
2030
First posted
Sep 22, 2022
Registry last updated
Feb 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.